Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Move Forward 3D Motion Simulation Service

K-Number: K162559 · 2017-03-31

ApplicantBiomet, Inc.
Decision Date2017-03-31
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Move Forward 3D Motion Simulation Service is a medical device manufactured by Biomet, Inc.. It received FDA 510(k) clearance on 2017-03-31 under approval number K162559. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Move Forward 3D Motion Simulation Service?

Move Forward 3D Motion Simulation Service is a medical device that received FDA 510(k) clearance on 2017-03-31. It is manufactured by Biomet, Inc.. The 510(k) number is K162559.

When was Move Forward 3D Motion Simulation Service approved by the FDA?

Move Forward 3D Motion Simulation Service received FDA 510(k) clearance on 2017-03-31, under approval number K162559.

What company makes Move Forward 3D Motion Simulation Service?

Move Forward 3D Motion Simulation Service is manufactured by Biomet, Inc..

What is the FDA product code for Move Forward 3D Motion Simulation Service?

The FDA product code for Move Forward 3D Motion Simulation Service is LLZ.

Related Clinical Trials

Other Devices by Biomet, Inc.

View all 34 devices →

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.